Title:
SOLUBLE MODIFIED RESPIRATORY SYNCYTIAL VIRUS (RSV) F PROTEIN ANTIGEN
Document Type and Number:
WIPO Patent Application WO/2019/066437
Kind Code:
A1
Abstract:
The present invention relates to a soluble respiratory syncytial virus (RSV) F protein and comprises immunogenic compositions such as vaccines for treatment and/or prevention of RSV infection.
Inventors:
KIM EUN-SOM (KR)
KWON TEAWOO (KR)
KIM HAK (KR)
SEO KI-WEON (KR)
LEE SU JEEN (KR)
KIM JIN-SEOL (KR)
KIM CHANG SHIN (KR)
HAM DONG SOO (KR)
KIM HUN (KR)
KWON TEAWOO (KR)
KIM HAK (KR)
SEO KI-WEON (KR)
LEE SU JEEN (KR)
KIM JIN-SEOL (KR)
KIM CHANG SHIN (KR)
HAM DONG SOO (KR)
KIM HUN (KR)
Application Number:
PCT/KR2018/011324
Publication Date:
April 04, 2019
Filing Date:
September 21, 2018
Export Citation:
Assignee:
SK BIOSCIENCE CO LTD (KR)
International Classes:
C07K14/005; A61K39/00; A61K39/12; A61K39/39
Domestic Patent References:
| WO2009128951A2 | 2009-10-22 |
Foreign References:
| US20140271699A1 | 2014-09-18 | |||
| US20140024076A1 | 2014-01-23 |
Other References:
PIERANTONI, ANGIOLO ET AL.: "Mucosal Delivery of a Vectored RSV Vaccine Is Safe and Elicits Protective Immunity in Rodents and Nonhuman Primates", MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, vol. 2, no. 15018, 2015, pages 1 - 11, XP055524844
MCLELLAN, JASON S. ET AL.: "Structure-based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, vol. 342, 1 November 2013 (2013-11-01), pages 592 - 598, XP055391357
MCLELLAN, JASON S. ET AL.: "Structure-based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, vol. 342, 1 November 2013 (2013-11-01), pages 592 - 598, XP055391357
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
Download PDF: